BioIndustry Association appoints new board of directors
This article was originally published in Scrip
The BioIndustry Association (BIA) has appointed five new members to its board of directors: Dr John Brown, chairman of BTG and CXR Biosciences; Paul Drohan, general manager and vice-president of Genzyme UK and Ireland; Steven Harris, CEO of Circassia; Dr Ed Hodgkin, CEO of Biotica Technology; and Dr Sam Williams, CEO of Modern Biosciences. The BIA, which encourages and promotes the bioscience sector within the UK economy, also re-elected Kate Bingham, managing partner at SV Life Sciences; Tim Edwards, president and CEO of Cellzome; Dr Jeremy Haigh, vice-president and international chief operating officer, R&D, at Amgen; Geoff Newman, co-founder and managing director of Interea International; Ian Nicholson, CEO of Chroma Therapeutics; and Peter Nolan, executive director and senior vice-president of commercial development at Oxford BioMedica. All board members will serve from January 1st onwards.